The ruthenium-based anticancer agent BOLD-100 just received an Orphan Drug Designation in the treatment of gastric (stomach) cancer from the U.S. Food...
The research cluster "Translational Cancer Therapy Research" was successful in a new call by the University of Vienna and Medical University of Vienna...